What did @jacobnickelsonn actually say?
The creator described experiencing depression and emotional flatness while using BPC-157 for a shoulder injury, then advised a follower to stop taking it immediately. He attributed this to BPC-157 potentially "down regulating" something in people with "certain genes" or "certain urology." He also claimed TB-500 doesn't produce the same mood-related side effects, and that BPC-157 is "way more" healing than TB-500. He then pivoted to coaching offers and a list of alternatives including TB-500, copper GHK, topical exosomes, and red light therapy.
To his credit, he did recommend the follower get an MRI before deciding on a treatment path. That part is reasonable. The rest of it is a mix of plausible observation, speculative biology, and some genuinely problematic framing that deserves a closer look.
Does the science back this up?
Mood changes from BPC-157 are biologically plausible, but the "certain genes" explanation is pure speculation with no peer-reviewed backing. What we do know is more nuanced.
BPC-157 interacts with dopaminergic and serotonergic systems. Research in rodents has shown it can modulate dopamine receptor expression and influence nitric oxide pathways, both of which have downstream effects on mood (Sikiric et al., 2018, Current Neuropharmacology). Some users report transient anxiety or low mood, particularly at higher doses or in the early phase of use. However, these effects have not been systematically studied in humans in controlled trials. There are no published human RCTs on BPC-157 at all, which is worth saying clearly.
The "down regulates the opening" language the creator used is not a recognized pharmacological concept. It may gesture at receptor downregulation, but it's vague enough to be meaningless as stated. Comparing it to specific genetic variants without citing any mechanism or study is not science communication. It's pattern-matching from personal experience.
What did they get wrong (or right)?
He got the core observation right: mood changes are a reported side effect of BPC-157, and they appear to be more common than mainstream peptide marketing admits. That's a fair point, and giving credit here matters because the bodybuilding community often dismisses these reports entirely.
Where he went wrong is the mechanism. "Certain genes" and "certain urology" are not explanations. They are placeholders for an explanation. Presenting speculation with that level of confidence to 24,900 viewers on a peptide forum is a problem.
The claim that TB-500 "does nearly hardly any" healing compared to BPC-157 is also overstated. TB-500 (thymosin beta-4) has demonstrated anti-inflammatory and angiogenic properties in preclinical models (Philp et al., 2004, Annals of the New York Academy of Sciences). Calling it barely effective relative to BPC-157 isn't supported by head-to-head data because that data doesn't exist.
Recommending topical exosomes for shoulder injuries is also worth flagging. Exosome therapies are largely unregulated, variable in quality, and lack clinical trial support for musculoskeletal use in outpatient settings.
What should you actually know?
If you're experiencing depression or significant mood changes while using any peptide, stopping use and contacting a clinician is the right call. The creator's advice to "get off of it as soon as possible" was appropriate. Self-managing peptide-induced mood symptoms based on TikTok guidance is not.
BPC-157 remains unscheduled but unapproved by the FDA for human use. All available human data is anecdotal or case-report level. Animal models show real effects on tissue repair and neurotransmitter systems (Chang et al., 2011, Journal of Physiology-Paris), but extrapolating those findings directly to human dosing and side effect profiles involves significant uncertainty.
Mood-related side effects from peptides that interact with dopamine and serotonin pathways are plausible and worth taking seriously. If you're using BPC-157 and notice changes in mood, motivation, or emotional regulation, those experiences are real even if the mechanism isn't fully understood. That's not the same as the creator's gene theory being correct. It just means the anecdotal signal probably deserves more formal research attention than it gets.